FDA Drug recall D-0082-2019
Clonazepam Orally Disintegrating Tablets USP, 2 mg., 60-count carton
- FDA Drug
- Class II
- terminated
- Published 2018-10-24
On 2018-10-24 the FDA classified a Class II recall of Clonazepam Orally Disintegrating Tablets USP, 2 mg., 60-count carton by Teva Pharmaceuticals Usa, citing failed Stability Specifications: Out-of-specification test result for water content obtained during routine stability testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0082-2019 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-09-20 |
| Published | 2018-10-24 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Teva Pharmaceuticals Usa |
| Distribution | US |
Product
Clonazepam Orally Disintegrating Tablets USP, 2 mg., 60-count carton. RX only. Teva Pharmaceuticals USA, INC. North Whales, PA 19454. NDC 0555-0098-96
Reason
Failed Stability Specifications: Out-of-specification test result for water content obtained during routine stability testing.
Identifiers
| code_info | Lot # 34033752A, EXP 1/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0082-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.